Omeprazol Aristo (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Aristo, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is employed to treat gastro‑oesophageal reflux disease, peptic ulcer disease and related acid‑related disorders in adults.

GNH USA supplies Omeprazol Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Aristo is a proton pump inhibitor that acts on the gastric parietal cell acid‑secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal erosion. - Peptic ulcer disease: accelerates ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls pathological gastric acid hypersecretion.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be transient. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort in the stomach region.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome): require immediate medical attention. - Clostridioides difficile infection: presents with severe diarrhea. - Hypomagnesemia: low magnesium levels that can cause muscle cramps or cardiac arrhythmia. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Bone fracture risk: potential reduction in bone mineral density with long‑term use. - Vitamin B12 deficiency: may develop after prolonged therapy.

Before initiating therapy, consider the following precautions: - Renal function assessment: adjust use in severe renal impairment. - H. pylori status: test and treat infection before long‑term therapy. - Duration of use: employ the lowest effective dose for the shortest necessary period. - Concomitant medications: review for potential interactions that may affect efficacy or safety. - Known hypersensitivity: avoid in patients with documented allergy to omeprazole or other PPIs. - Store at room temperature: keep in the original container, protect from moisture and light.

Omeprazol Aristo may interact with several medicines. Monitor and manage as follows: Major Interactions (Avoid): - Clopidogrel: omeprazole can reduce antiplatelet activity, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to sub‑therapeutic antiviral levels. - Warfarin: potential increase in INR and bleeding risk. Moderate Interactions (Monitor Closely): - Digoxin: higher serum concentrations may occur. - Phenytoin: omeprazole may lower phenytoin levels, reducing seizure control.